Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.